Therapeutic Equivalence of Complex Molecules and Formulations
Monday & Tuesday, September 10-11, 2018
Banting Auditorium, Sir Frederick Banting Building,
Tunney’s Pasture Campus, Ottawa ON
The CSPS is a national voluntary professional society of members committed to establishing a network of pharmaceutical scientists in Canada in pursuit of excellence in research, development and training. CSPS conferences and workshops support the goals for facilitating research, policy development, information sharing, and promotion of best knowledge and practices throughout Canada.
CSPS Workshop 2018
The proposed theme for the CSPS Workshop 2018 includes the pharmaceutical sciences in therapeutic equivalence of complex molecules and their formulation science. Therapeutic equivalence is constantly evolving and innovating to the challenges of modern issues and health system requirements. There is an abundance of contemporary interest in the science and policies in the duplication of complex molecules. This desire results in the need to advance and innovate formulation science to harness the advantages of unique drug release technologies and apply them to practice pharmacology.
Forum & Location 2018
A two-day collaborative workshop is planned with Health Canada, its scientific staff, and the pharmaceutical community of scientists from academia, brand and generic industries, in keeping with the mission of CSPS.
The workshop will be held September 10-11, 2018, in the Banting Auditorium, Sir Frederick Banting Building, Tunney’s Pasture Campus in Ottawa, Ontario.
Faculty of Speakers and Panelists
Health Canada and its scientific staff, the pharmaceutical community of scientists from academia, brand and generic industries, and policy and patient advocates.
Collaboration and Sponsorship
Health Canada’s unique collaboration in-kind (venue and speakers); the pharmaceutical community and industry (sponsorship and speakers).
All participants will be pre-registered; workshop fees to be determined. Registration fees will be waived for speakers, panelists, chairs, and Health Canada registrants.
Suggested by the CSPS corporate members, and with open discussion to solicit your contribution and refinement.
- Synthetic and semisynthetic proteins and peptides
- More topics will be included, for example: mixtures of complex molecules where the contribution of each compound is unclear or unknown
Subsequent Entry of Products with Special Characteristics:
- Long acting bronchodilators
- Multiphasic release formulations
- Modified-release injectable products
- Modified release formulations of narrow therapeutic window drugs
- Narcotic analgesics
- Oral products intended for local gastrointestinal effects
- Abuse-deterrent formulations of opioids
For information, contact:
Canadian Society for Pharmaceutical Sciences